Short answer
Immunome Inc. (IMNM) filed an 8-K current report with the SEC on May 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 results for quarter ended March 31, 2026, with business update.
Immunome Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results for quarter ended March 31, 2026, with business update
- Press release Exhibit 99.1 contains the substantive financial results and operating details
- Disclosure signals quarterly investor update; market impact depends on results and pipeline developments in Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Immunome Inc. 8-K filings
Get the next IMNM 8-K as it lands
Follow IMNM for push alerts, or ask the research agent what this filing means.